Therapy Areas: Vaccines
19 September 2018 - - US-based PCR-based DNA manufacturing specialist Applied DNA Sciences Inc. (NASDAQ: APDN) has formed LineaRx, Inc., a wholly owned subsidiary, the company said.

...
14 September 2018 - - US-based drug and vaccine developer CEL-SCI Corp. (NYSE American: CVM)  has received USD 5,435,367 through the exercise of warrants to purchase shares of the company�...
13 September 2018 - - US-based biotechnology vaccines developer TechnoVax, Inc has received a two-year USD 1.481m SBIR-II grant from the National Institute of Allergy and Infectious Diseases (NIAID) o...
11 September 2018 - - Apivotal Phase 3 clinical study evaluating US-based pharmaceutical company Merck and Co., Inc.'s (NYSE: MRK) antibiotic Zerbaxa (ceftolozane and tazobactam) at an investigat...
11 September 2018 - - US-based clinical stage company ImmusanT, Inc has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the b...
11 September 2018 - French biotech company Neovacs (Euronext Growth Paris: ALNEV) will receive a milestone payment after its partner Biosense Global exercised its option to acquire the exclusive licen...